May 28

SYDNEY, May 28, 2011 - Sydney has been transformed tonight into a colourful canvas of light with the launch of the third annual Vivid Sydney festival - the largest celebration of light, music and ideas in the Southern Hemisphere, from the 27 May - 13 June 2011.

CARLSBAD, California, May 28, 2011 - - The Ion Total RNA-Seq Kit, created in partnership with Life Technologies' Ambion(R) division, provides far more accurate and comprehensive data Life Technologies Corporation (www.lifetechnologies.com) (NASDAQ: LIFE) today announced it is now shipping the Ion Total RNA-Seq Kit (find.lifetechnologies.com/ionrnaseq/pr/ion-rnaseq-regional-86MH-784EI.html) for the Ion Personal Genome Machine (PGM(TM)) sequencer, a solution that provides a fast, affordable, easy-to-use alternative to microarrays for transcript expression analysis.

ROME, May 28, 2011 - - In Partnership With the European Neurological Society ( ENS ) SSIF Announces the Establishment of a Prestigious Award to Recognize and Reward Excellence in Medical Education Serono Symposia International Foundation (SSIF) has announced today a public competition for an Award to recognise an expert in the field of neurology who has made a significant contribution to medical education activities through research and dedication.

SEOUL, South Korea, May 28, 2011 - - THIS MEDIA ALERT IS INTENDED FOR HONG KONG, NEW ZEALAND, THE PHILIPPINES, SINGAPORE AND THAILAND ONLY - New Data Presented at World Congress of Dermatology STELARA(R) has shown sustained efficacy in Japanese patients with moderate to severe psoriasis over 12 months according to new data presented today at the World Congress of Dermatology (WCD).[1] Psoriasis, a chronic, immune-mediated disease that results from the overproduction of skin cells, affects 125 million people worldwide.

VANCOUVER, British Columbia, May 28, 2011 - - Company's Novel Biomarker and Drug Target Could Represent the First Personalized Medicine in RA-Promise for Future Targeted Therapy in a Multi-factorial Disease Augurex Life Sciences Corp.